Trends and patterns of antipsychotic medication use during pregnancy: A population‐based study
British Journal of Clinical Pharmacology · 10.11.2026
DOI: 10.1002/bcp.70899 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 10.11.2026. Verfasst von Dervla Quinn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Public Health (CPH), Queen's University Belfast, Belfast, UK. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department for the Economy NI, Economic and Social Research Council, Irish Health Research Board, DfE, Alzheimer's Research UK, Lewy Body Society.
Abstract (Originalsprache)
Aim
The prescription of antipsychotic medication during pregnancy, particularly second‐generation antipsychotics, has increased in several countries in recent decades. This population‐based study investigated trends and patterns in antipsychotic medication use during pregnancy between 2011 and 2023 in Northern Ireland (NI), UK. The purpose was to improve understanding about how these medicines are used during pregnancy, including patterns of antipsychotic discontinuation across pregnancy.
Methods
Data from the Northern Ireland Maternity System (NIMATS) were linked to dispensed prescribing data from the Enhanced Prescribing Database (EPD) and the NI Multiple Deprivation Measure 2017 (NIMDM). Overall temporal trends were identified, and subsequently stratified by subtype (first‐ and second‐generation antipsychotics [FGAs and SGAs]). Usage was evaluated by pregnancy exposure period (12 weeks before pregnancy and by trimester). A separate analysis investigated patterns across trimesters in women who had been dispensed antipsychotics 12 weeks before pregnancy, including concomitant dispensing of antidepressants.
Results
The cohort included 287 757 singleton pregnancies in 175 938 women aged over 16 years, with an overall prevalence of antipsychotic use of 79.9 per 10 000 pregnancies. The prevalence of antipsychotic usage increased by 71% from 59 to 101 per 10 000 pregnancies between 2011 and 2023 ( p = .001). SGA usage almost tripled from 32 to 93 per 10 000 pregnancies, whereas FGA usage decreased by 73% from 30 to 8 per 10 000 pregnancies in 2011 compared with 2023. Overall usage of antipsychotics decreased across trimesters.
Conclusion
Overall antipsychotic prevalence during pregnancy increased over the study period, most notably SGA usage, whereas FGA usage decreased.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Public Health (CPH), Queen's University Belfast, Belfast, UK.
- Psychiatry of Old Age, Belfast Health and Social Care Trust, Belfast, UK.
- Centre for Fetal Medicine, Belfast Health and Social Care Trust, Belfast, UK.
ORCID-Profile: Dervla Quinn
Förderung
- Department for the Economy NI
- Economic and Social Research Council
- Irish Health Research Board, DfE, Alzheimer's Research UK, Lewy Body Society
- ADR UK
Zitieren
APA
Quinn, D., Donnelly, M., Heron, N., Kane, J., Kent, L., Mone, F., & O'Neill, C. (2026). Trends and patterns of antipsychotic medication use during pregnancy: A population‐based study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70899
Vancouver
Quinn D, Donnelly M, Heron N, Kane J, Kent L, Mone F, et al. Trends and patterns of antipsychotic medication use during pregnancy: A population‐based study. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70899
BibTeX
@article{Quinn2026,
author = {Quinn, Dervla and Donnelly, Michael and Heron, Neil and Kane, Joseph and Kent, Lisa and Mone, Fionnuala and O'Neill, Ciaran},
title = {Trends and patterns of antipsychotic medication use during pregnancy: A population‐based study},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70899}
}
EUVIMED